News
Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...
The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...
The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...
7h
Zacks Investment Research on MSNIntellia Gains 29.8% in a Month: How Should You Play the Stock?Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% ...
11h
United News of Bangladesh on MSNCRISPR gene editing reshaping medicine, offering hope for genetic diseasesCRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.
Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...
A breakthrough in genetic editing allows IVF parents to select traits for their embryo. But some experts are warning this new ...
Abu Dhabi: The Department of Health – Abu Dhabi, the emirate’s healthcare sector regulator, has announced a landmark ...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...
Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results